Αποτελέσματα Αναζήτησης
12 Ιουν 2023 · In this work, we hypothesized cancer chemotherapeutics would influence the efficacy of bacteriophages.
- Full Size Image
We would like to show you a description here but the site...
- Full Size Table
We would like to show you a description here but the site...
- Full Size Image
10 National Centre for Infections in Cancer, University of Melbourne, Melbourne, Australia . ... a The usual duration of IV treatment for Staphylococcus aureus bloodstream infection is 14–42 days in adults and 7–14 days in children; ... The per-protocol population is defined as: the combination group that received at least 75% of ...
3 Μαΐ 2023 · Staphylococcus aureus is a major cause of nosocomial and community-acquired infections and contributes to significant increase in morbidity and mortality especially when associated with medical devices and in biofilm form.
12 Ιουν 2023 · We meaningfully discovered that Doxorubicin promoted the efficiency in eradicating cell-associated bacteria, which can be further considered as an adjuvant of phage therapy in the treatment of bacterial infections for cancer patients.
Background: Staphylococcus aureus bloodstream infections (SABIs) represent a significant cause of morbidity and mortality in cancer patients. In this study, we compared infection characteristics and evaluated epidemiology and risk factors associated to SABIs and 30-day attributable mortality in cancer patients.
18 Απρ 2023 · Infections in cancer patients are increasingly often caused by resistant organisms, which threaten recent years’ advances in the treatment of cancer [6]. Recent studies has shown that cancer patients have a higher risk of contracting infections with antimicrobial-resistant organisms [7].
Staphylococci, particularly coagulase negative Staphylococci (CoNS) are noteworthy pathogens in such cases, and the emergence of multi-drug resistance in Staphylococci is a cause of concern.
